E, J., M, K., NV, H., S, B., N, P., R, H., & R, E. (2024). Treatment of acute kidney injury with continuous renal replacement therapy and cytokine adsorber (CytoSorb®) in critically ill patients with COVID-19. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 28(6), 941. https://doi.org/10.1111/1744-9987.14182
Chicago Style (17th ed.) CitationE, Jakopin, Knehtl M, Hojs NV, Bevc S, Piko N, Hojs R, and Ekart R. "Treatment of Acute Kidney Injury with Continuous Renal Replacement Therapy and Cytokine Adsorber (CytoSorb®) in Critically Ill Patients with COVID-19." Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 28, no. 6 (2024): 941. https://doi.org/10.1111/1744-9987.14182.
MLA (9th ed.) CitationE, Jakopin, et al. "Treatment of Acute Kidney Injury with Continuous Renal Replacement Therapy and Cytokine Adsorber (CytoSorb®) in Critically Ill Patients with COVID-19." Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, vol. 28, no. 6, 2024, p. 941, https://doi.org/10.1111/1744-9987.14182.